Skip to content

Clinical trials

Completed Carcinoma trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma Status: Completed Country / region: China Clear all

25 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20062
20072
20082
20092
20101
20111
20122
20141
20151
20161
20172
20192
20201
20213
20221
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed25

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Peking University People's Hospital3
Bayer2
Pfizer2
Sanofi2
AstraZeneca1
BeiGene1
Changsha Medical University1
Chinese Academy of Medical Sciences1
Creative Biosciences (Guangzhou) Co., Ltd.1
Eastern Hepatobiliary Surgery Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma25
Carcinoma, Non-Small-Cell Lung6
Lung Neoplasms6
Carcinoma, Hepatocellular5
Neoplasms5
Adenocarcinoma4
Digestive System Neoplasms3
Digestive System Diseases2
Liver Neoplasms2
Neoplasms by Histologic Type2

Trials

Showing 1 to 25 of 25. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.